Clinical Trials & Results
Search or filter the listing below to find a trial or results of a completed trial.
Showing 3 of 3 Results
All Results
No Results
No results found
Please change the filter settings to find the product(s) you are looking for. You can also use the search function to look up a product.
Efficacy, Safety and Tolerability Study of Glatiramer Acetate in Subjects With Multiple Sclerosis
- Condition(s):
- Relapsing-Remitting Multiple Sclerosis
- Status:
- Terminated
- Requirements:
- 18 Years to 55 Years
- Interventions:
- Drug: Glatiramer Acetate | Drug: Placebo
Glatiramer Acetate Follow-up in Participants From the Original Study for Safety and Effectiveness
- Condition(s):
- Relapsing-Remitting Multiple Sclerosis
- Status:
- Completed
- Requirements:
- 18 Years and older
- Interventions:
- Drug: Glatiramer acetate
Safety and Tolerability of Glatiramer Acetate (GLACIER)
- Condition(s):
- Relapsing-Remitting Multiple Sclerosis
- Status:
- Completed
- Requirements:
- 18 Years and older
- Interventions:
- Drug: GA 20 mg/mL | Drug: GA 40 mg/mL